Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jul 13;12(7):917.
doi: 10.3390/brainsci12070917.

Sex Differences in Parkinson's Disease: From Bench to Bedside

Maria Claudia Russillo  1 , Valentina Andreozzi  1 , Roberto Erro  1 , Marina Picillo  1 , Marianna Amboni  1 , Sofia Cuoco  1 , Paolo Barone  1 , Maria Teresa Pellecchia  1
Affiliations

Sex Differences in Parkinson's Disease: From Bench to Bedside

Maria Claudia Russillo et al. Brain Sci. .

Abstract

Background: Parkinson's disease (PD) is the second most common neurodegenerative disorder after Alzheimer's disease and gender differences have been described on several aspects of PD. In the present commentary, we aimed to collect and discuss the currently available evidence on gender differences in PD regarding biomarkers, genetic factors, motor and non-motor symptoms, therapeutic management (including pharmacological and surgical treatment) as well as preclinical studies.

Methods: A systematic literature review was performed by searching the Pubmed and Scopus databases with the search strings "biomarkers", "deep brain stimulation", "female", "gender", "genetic", "levodopa", "men", "male", "motor symptoms", "non-motor symptoms", "Parkinson disease", "sex", "surgery", and "women".

Results: The present review confirms the existence of differences between men and women in Parkinson Disease, pointing out new information regarding evidence from animal models, genetic factors, biomarkers, clinical features and pharmacological and surgical treatment.

Conclusions: The overall goal is to acquire new informations about sex and gender differences in Parkinson Disease, in order to develop tailored intervetions.

Keywords: Parkinson’s disease; gender; sex.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Picillo M., Nicoletti A., Fetoni V., Garavaglia B., Barone P., Pellecchia M.T. The relevance of gender in Parkinson’s disease: A review. J. Neurol. 2017;264:1583–1607. doi: 10.1007/s00415-016-8384-9. - DOI - PubMed
    1. Lee Y., Park Y.H., Lee J.J., Sohn Y.H., Lee J.M., Lee P.H. Gender-specific effect of uric acid on resting-state functional networks in de novo Parkinson’s disease. Park. Relat. Disord. 2018;52:49–54. doi: 10.1016/j.parkreldis.2018.03.023. - DOI - PubMed
    1. Loesch D.Z., Tassone F., Mellick G.D., Horne M., Rubio J.P., Bui M.Q., Francis D., Storey E. Evidence for the role of FMR1 gray zone alleles as a risk factor for parkinsonism in females. Mov. Disord. 2018;33:1178–1181. doi: 10.1002/mds.27420. - DOI - PMC - PubMed
    1. Baik K., Chung S.J., Yoo H.S., Lee Y.H., Jung J.H., Sohn Y.H., Lee P.H. Sex-dependent association of urate on the patterns of striatal dopamine depletion in Parkinson’s disease. Eur. J. Neurol. 2020;27:773–778. doi: 10.1111/ene.14152. - DOI - PubMed
    1. Yang K., Shen B., Li D.-K., Wang Y., Zhao J., Zhao J., Yu W.-B., Liu Z.-Y., Tang Y.-L., Liu F.-T., et al. Cognitive characteristics in Chinese non-demented PD patients based on gender difference. Transl. Neurodegener. 2018;7:16. doi: 10.1186/s40035-018-0120-1. - DOI - PMC - PubMed

LinkOut - more resources